9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine and HIV

9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine has been researched along with HIV in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balzarini, J; De Clercq, E; Holý, A; Naesens, L; Rosenberg, I	1

Other Studies

1 other study(ies) available for 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine and HIV

Article	Year
9-(2-Phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP): a novel agent with anti-human immunodeficiency virus activity in vitro and potent anti-Moloney murine sarcoma virus activity in vivo. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:12 Topics: Adenine; Animals; Antiviral Agents; Cell Line; Drug Evaluation, Preclinical; Embryo, Mammalian; HIV; Humans; Mice; Moloney murine sarcoma virus; Sarcoma Viruses, Murine; T-Lymphocytes; Virus Replication	1989

Article

Year

9-(2-Phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP): a novel agent with anti-human immunodeficiency virus activity in vitro and potent anti-Moloney murine sarcoma virus activity in vivo.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:12

Topics: Adenine; Animals; Antiviral Agents; Cell Line; Drug Evaluation, Preclinical; Embryo, Mammalian; HIV; Humans; Mice; Moloney murine sarcoma virus; Sarcoma Viruses, Murine; T-Lymphocytes; Virus Replication

1989